Company / Accounts Receivable
Cosmos Health Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$19.6M
FY2025
5-year range
$13.5M / $26.5M
FY2021-FY2025
Trend
+45.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable returned to growth in FY2025 after 3 years of decline, reaching $20M.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of -3.5%.
Remained stable around $20M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -6.1%
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.5%, indicating a declining trend.
- In FY2025, accounts receivable increased 45.6% year-over-year.
- Peak accounts receivable was recorded in FY2021.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.6M | +45.6% |
| FY2024 | $13.5M | -31.8% |
| FY2023 | $19.8M | -16.6% |
| FY2022 | $23.7M | -10.6% |
| FY2021 | $26.5M | +13.0% |
| FY2020 | $23.4M | +219.0% |
| FY2019 | $7.3M | +54.6% |
| FY2018 | $4.8M | +278.6% |
| FY2017 | $1.3M | +89.7% |
| FY2016 | $661.9K | +585.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026